Found 5 matching trials
To Compare the PK, PD, Safety & Immunogenicity of ADL-018 in Healthy Subjects
PHASE1This will be a randomized, double blind, three-arm, single dose, parallel g...
Location
Registered BABE centre
To Compare the PK and Safety of Omalizumab (CT-P39, EU-approved Xolair, and US-licensed Xolair) in Healthy Subjects
PHASE1A Phase 1, Randomized, Double-blind, Three-arm, Parallel Group, Single-dose...
Biosimilar Study Comparing PK, PD, Safety and Immunogencity of BP11 With US Licensed Xolair and EU Approved Xolair
PHASE1A single dose, double blind comparative trial to assess the pharmacokinetic...
Study to Compare Efficacy Safety and Immunogenicity of ADL-018 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria
PHASE3The purpose of the study is to compare the efficacy, safety, tolerability, ...
Location
True Blue Clinical Research
PK, PD, Safety & Immunogenicity of ADL-018 Lyo in Healthy Adult Subjects
PHASE1This will be a randomized, double blind, two-arm, single dose, parallel gro...
Location
Registered BE centre